Bioengineered corneal tissue for minimally invasive vision restoration in advanced keratoconus in two clinical cohorts Nature Biotechnology The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida